[go: up one dir, main page]

IT1274015B - USE OF CERULETIDE (TAKUS) IN THE TREATMENT OF PSORIASIS - Google Patents

USE OF CERULETIDE (TAKUS) IN THE TREATMENT OF PSORIASIS

Info

Publication number
IT1274015B
IT1274015B ITMI940298A ITMI940298A IT1274015B IT 1274015 B IT1274015 B IT 1274015B IT MI940298 A ITMI940298 A IT MI940298A IT MI940298 A ITMI940298 A IT MI940298A IT 1274015 B IT1274015 B IT 1274015B
Authority
IT
Italy
Prior art keywords
ceruletide
psoriasis
treatment
takus
Prior art date
Application number
ITMI940298A
Other languages
Italian (it)
Inventor
Keokharovna Kelesheva Lamara
Original Assignee
Theokhar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theokhar filed Critical Theokhar
Publication of ITMI940298A0 publication Critical patent/ITMI940298A0/en
Priority to ITMI940298A priority Critical patent/IT1274015B/en
Priority to IL11257895A priority patent/IL112578A0/en
Priority to HU9503295A priority patent/HU9503295D0/en
Priority to MX9504335A priority patent/MX9504335A/en
Priority to EP95914489A priority patent/EP0696203A1/en
Priority to ZA951137A priority patent/ZA951137B/en
Priority to AU21465/95A priority patent/AU2146595A/en
Priority to PL95311159A priority patent/PL311159A1/en
Priority to PCT/IB1995/000282 priority patent/WO1995022346A1/en
Priority to JP7521701A priority patent/JPH08509245A/en
Priority to CA002160251A priority patent/CA2160251A1/en
Publication of ITMI940298A1 publication Critical patent/ITMI940298A1/en
Priority to FI954912A priority patent/FI954912A/en
Priority to NO954115A priority patent/NO954115L/en
Application granted granted Critical
Publication of IT1274015B publication Critical patent/IT1274015B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Viene rivendicato l'uso del ceruletide nel trattamento della psoriasi.The use of ceruletide in the treatment of psoriasis is claimed.

ITMI940298A 1994-02-18 1994-02-18 USE OF CERULETIDE (TAKUS) IN THE TREATMENT OF PSORIASIS IT1274015B (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
ITMI940298A IT1274015B (en) 1994-02-18 1994-02-18 USE OF CERULETIDE (TAKUS) IN THE TREATMENT OF PSORIASIS
IL11257895A IL112578A0 (en) 1994-02-18 1995-02-08 Pharmaceutical compositions comprising ceruletide diethyl amine salt for the treatment of psoriasis
AU21465/95A AU2146595A (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
JP7521701A JPH08509245A (en) 1994-02-18 1995-02-13 Use of ceruletide diethylamine salt in the treatment of psoriasis
EP95914489A EP0696203A1 (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
ZA951137A ZA951137B (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
HU9503295A HU9503295D0 (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
PL95311159A PL311159A1 (en) 1994-02-18 1995-02-13 Pharmaceutical composition for treating psoriasis
PCT/IB1995/000282 WO1995022346A1 (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
MX9504335A MX9504335A (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis.
CA002160251A CA2160251A1 (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
FI954912A FI954912A (en) 1994-02-18 1995-10-16 Use of ceruletide-ditylamine salt in the treatment of psoriasis
NO954115A NO954115L (en) 1994-02-18 1995-10-16 Use of ceruletide-diethylamine salt in the treatment of psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI940298A IT1274015B (en) 1994-02-18 1994-02-18 USE OF CERULETIDE (TAKUS) IN THE TREATMENT OF PSORIASIS

Publications (3)

Publication Number Publication Date
ITMI940298A0 ITMI940298A0 (en) 1994-02-18
ITMI940298A1 ITMI940298A1 (en) 1995-08-19
IT1274015B true IT1274015B (en) 1997-07-14

Family

ID=11367909

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI940298A IT1274015B (en) 1994-02-18 1994-02-18 USE OF CERULETIDE (TAKUS) IN THE TREATMENT OF PSORIASIS

Country Status (13)

Country Link
EP (1) EP0696203A1 (en)
JP (1) JPH08509245A (en)
AU (1) AU2146595A (en)
CA (1) CA2160251A1 (en)
FI (1) FI954912A (en)
HU (1) HU9503295D0 (en)
IL (1) IL112578A0 (en)
IT (1) IT1274015B (en)
MX (1) MX9504335A (en)
NO (1) NO954115L (en)
PL (1) PL311159A1 (en)
WO (1) WO1995022346A1 (en)
ZA (1) ZA951137B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034531C2 (en) * 1980-09-12 1986-09-18 Farmitalia Carlo Erba S.p.A., Mailand/Milano Use of polypeptides as analgesics in human and veterinary medicine
JPS6041052B2 (en) * 1981-04-07 1985-09-13 塩野義製薬株式会社 psychotropic drugs

Also Published As

Publication number Publication date
NO954115D0 (en) 1995-10-16
FI954912A0 (en) 1995-10-16
ITMI940298A1 (en) 1995-08-19
NO954115L (en) 1995-10-16
CA2160251A1 (en) 1995-08-24
IL112578A0 (en) 1995-05-26
ZA951137B (en) 1995-12-01
MX9504335A (en) 1997-05-31
WO1995022346A1 (en) 1995-08-24
EP0696203A1 (en) 1996-02-14
AU2146595A (en) 1995-09-04
ITMI940298A0 (en) 1994-02-18
FI954912A (en) 1995-10-16
HU9503295D0 (en) 1996-01-29
JPH08509245A (en) 1996-10-01
PL311159A1 (en) 1996-02-05

Similar Documents

Publication Publication Date Title
ES2139574T3 (en) NEW PROPELLER GASES AND THEIR USE IN MEDICAL PREPARATIONS.
TR199701212T1 (en) Use of alpha IL-agonists for the treatment of urinary incontinence.
PL323825A1 (en) Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin
ITBO910163A0 (en) USE OF GLYCOSAMINOGLICANS IN THE TREATMENT OF DIABETIC NEPHROPATHY AND DIABETIC NEUROPATHY
ES2125358T3 (en) AGENTS FOR WATER CLARIFICATION WITH QUATERNIZED POLYVINYLAMINES.
ES2151607T3 (en) GROWTH AND DIFFERENTIATION FACTOR 12.
DE58908544D1 (en) Benzamide against cognitive disorders.
IT1264965B1 (en) USE OF ALFA 1-BLOCCANTI IN THE TREATMENT OF EARLY EJACULATION
FI864570A0 (en) THERAPEUTIC ANVAENDBAR FOERENING.
ITMI912509A0 (en) USE OF NIMESULIDE IN THE TREATMENT OF CATARACT
FI852730L (en) (PYRROL-1-YL) -PHENYL-DIHYDROPYRIDAZINONER, DERAS FRAMSTAELLNING OCH ANVAENDNING.
FI830523A0 (en) ANTI-INFLAMMATORY OCH / ELLER SMAERTA LINDRANDE 2,3-DIARYL-5-HALOTIOFENER
BG101126A (en) The use of muramylpeptide compounds
IT1252603B (en) 2,4-DIAMINO-6 PIPERIDINO PIRIMIDINA-3 TOPICAL OXIDE ON THE GLAND IN THE TREATMENT OF ERECTILE IMPOTENCES
IT8420213A0 (en) PROCEDURE FOR THE PREPARATION OF 1,8-DIHYDROXY-10-ACYL-9-ANTHRONES, PARTICULARLY FOR USE IN THE TREATMENT OF PSORIASIS.
IT1274015B (en) USE OF CERULETIDE (TAKUS) IN THE TREATMENT OF PSORIASIS
GB8327598D0 (en) Pharmacologically active diarylindane-13-diones
IT1251497B (en) USE OF 1,2 DIPALMITOIL-L-ALFA-FOSFATIDIL-N, N-DIMETYLETHANOLAMINE, IN DERMATOLOGICAL COMPOSITIONS
BR9704964A (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of some psychomotor and psycho-intellectual disorders
ITMI941064A0 (en) USE OF S-BENZOYLOXYMETHYLTHIAMINE IN THE TREATMENT OF DIABETES
ITRM950686A1 (en) HCG IN THE SARCOMA OF KAPOSI
ITFI930069A1 (en) ORAL AND TOPICAL USE OF N-ACETYL-5-METHOXYRIPTAMINE (MELATONIN) IN THE THERAPY OF PSORIASIS Vulgaris.
ES2141923T3 (en) HIPOCOLESTEROLEMICO, ANTIATEROSCLEROTICO AND HIPOTRIGLYCERIDEMICO USE OF AMINOACETILMERCAPTO DERIVATIVES.
ES2173158T3 (en) REDUCTION OF ADIPOSE TISSUE USING COLAGENASA
IT1302920B1 (en) USE OF PROPOLIS IN THE TREATMENT OF VITILIGINE AND PSORIASIS.

Legal Events

Date Code Title Description
0001 Granted